These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12799856)

  • 1. [Animal models and their results in relation to the therapy of migraine].
    Kaube H; Limmroth V
    Schmerz; 1996 Jun; 10(3):114-20. PubMed ID: 12799856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental migraine models and their relevance in migraine therapy.
    Arulmani U; Gupta S; VanDenBrink AM; Centurión D; Villalón CM; Saxena PR
    Cephalalgia; 2006 Jun; 26(6):642-59. PubMed ID: 16686903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding migraine: Potential role of neurogenic inflammation.
    Malhotra R
    Ann Indian Acad Neurol; 2016; 19(2):175-82. PubMed ID: 27293326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1 receptors in migraine pathophysiology and treatment.
    Ferrari MD; Saxena PR
    Eur J Neurol; 1995 Mar; 2(1):5-21. PubMed ID: 24283575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of calcitonin gene-related peptide in trigeminal ganglion following chronic exposure to paracetamol in a CSD migraine animal model.
    Yisarakun W; Chantong C; Supornsilpchai W; Thongtan T; Srikiatkhachorn A; Reuangwechvorachai P; Maneesri-le Grand S
    Neuropeptides; 2015 Jun; 51():9-16. PubMed ID: 25998753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative role of neuroinflammation in the complex pathophysiology of migraine: From bench to bedside.
    Biscetti L; Cresta E; Cupini LM; Calabresi P; Sarchielli P
    Neurobiol Dis; 2023 May; 180():106072. PubMed ID: 36907522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache?
    Ebersberger A; Schaible HG; Averbeck B; Richter F
    Ann Neurol; 2001 Jan; 49(1):7-13. PubMed ID: 11198299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress.
    Wang M
    Neuropeptides; 2013 Dec; 47(6):463-6. PubMed ID: 24220568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Goadsby PJ; Edvinsson L
    Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trigemino-vascular system and migraine.
    Buzzi MG; Moskowitz MA
    Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
    J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathogenetic bases of hemicrania].
    Fanciullacci M; Alessandri M; Bandini EB
    Ann Ital Med Int; 1992; 7(3 Suppl):41S-45S. PubMed ID: 1297398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
    Bellamy JL; Cady RK; Durham PL
    Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for orexinergic mechanisms in migraine.
    Hoffmann J; Supronsinchai W; Akerman S; Andreou AP; Winrow CJ; Renger J; Hargreaves R; Goadsby PJ
    Neurobiol Dis; 2015 Feb; 74():137-43. PubMed ID: 25447225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mode of action of sumatriptan is vascular? A debate.
    Humphrey PP; Goadsby PJ
    Cephalalgia; 1994 Dec; 14(6):401-10; discussion 393. PubMed ID: 7697699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paranasal sinus nitric oxide and migraine: a new hypothesis on the sino rhinogenic theory.
    Rathnasiri Bandara SM
    Med Hypotheses; 2013 Apr; 80(4):329-40. PubMed ID: 23394937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.